JG

Jeena George

Active Director Director DIN 05163064
DIN 05163064 First appointment Sep 2011 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Jeena George

Data last updated:

Jeena George is a Director at Cnidus Pharma Private Limited (since 2011). The company operates in Chemicals.

DIN 05163064
Primary Designation Director
Industry Chemicals
First Appointment 29 Sep 2011
Oldest Company Age 20 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cnidus Pharma Private Limited U24232KL2006PTC019188
Director29 Sep 20112006Active

Directorship timeline

Open interactive timeline →
Cnidus Pharma Private Limited
Premium access

Shareholding and investment profile for Jeena George

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jeena George

Jeena George currently holds 1 directorship: Cnidus Pharma Private Limited (Director, since 29 Sep 2011).

Jeena George was first appointed on 29 Sep 2011 as Director at Cnidus Pharma Private Limited.

The current boards of Jeena George's companies include Chacko Mathai Mattathil (Cnidus Pharma Private Limited), Francis Thomas (Cnidus Pharma Private Limited), George Jacob (Cnidus Pharma Private Limited), George John (Cnidus Pharma Private Limited), George Joseph Mookken (Cnidus Pharma Private Limited), Mathews George (Cnidus Pharma Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available